share_log

TC BioPharm To Begin Proof Of Concept Preclinical Studies For Lead Therapy TCB008 To Treat Monkeypox; Aims To Partner With Infectious Disease Center For Rapid Advancement Of Studies

TC BioPharm To Begin Proof Of Concept Preclinical Studies For Lead Therapy TCB008 To Treat Monkeypox; Aims To Partner With Infectious Disease Center For Rapid Advancement Of Studies

TC BioPharm将开始进行概念性临床前研究,以治疗天花的主要疗法TCB008;旨在与传染病中心合作,快速推进研究。
Benzinga ·  09/06 16:02

TC BioPharm To Begin Proof Of Concept Preclinical Studies For Lead Therapy TCB008 To Treat Monkeypox; Aims To Partner With Infectious Disease Center For Rapid Advancement Of Studies

TC BioPharm将开始进行概念性临床前研究,以治疗天花的主要疗法TCB008;旨在与传染病中心合作,快速推进研究。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发